Saba Capital Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-80,556
Closed -$1.49M 375
2025
Q3
$1.49M Sell
80,556
-83,546
-51% -$1.36M 0.04% 173
2025
Q2
$2.54M Sell
164,102
-1,037,294
-86% -$16.1M 0.06% 141
2025
Q1
$19.5M Sell
1,201,396
-770,263
-39% -$13.2M 0.53% 38
2024
Q4
$31.6M Sell
1,971,659
-900,303
-31% -$16M 0.74% 30
2024
Q3
$53.5M Sell
2,871,962
-436,411
-13% -$8.13M 1.11% 24
2024
Q2
$57.8M Buy
3,308,373
+750,904
+29% +$12.5M 0.96% 21
2024
Q1
$43.1M Buy
2,557,469
+1,133,123
+80% +$19.3M 0.74% 28
2023
Q4
$23.6M Buy
1,424,346
+1,127,709
+380% +$17.3M 0.47% 52
2023
Q3
$4.61M Buy
296,637
+168,402
+131% +$2.81M 0.11% 153
2023
Q2
$2.19M Buy
+128,235
New +$2.22M 0.06% 222

Other funds holding HQH

Saba Capital Management's HQH Position: Q4 2025 in Review

Saba Capital Management sold out of abrdn Healthcare Investors (HQH) in Q4 2025, closing a stake of 80,556 shares — an estimated $1.49M sold.

Saba Capital Management first reported a position in HQH in Q2 2023 and held it in 10 quarters. The position peaked at $57.8M in Q2 2024. 123 funds tracked by Wall St. Rank hold HQH as of Q4 2025.

  • Saba Capital Management reported no remaining abrdn Healthcare Investors position as of Q4 2025 after selling out during the quarter.
  • Saba Capital Management sold 80,556 abrdn Healthcare Investors shares in Q4 2025, an estimated $1.49M.
  • Saba Capital Management first reported a position in abrdn Healthcare Investors in Q2 2023 and held it in 10 quarters.
  • Saba Capital Management's abrdn Healthcare Investors position peaked at $57.8M in Q2 2024.
  • 123 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q4 2025.

Based on Saba Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.